A randomized double-blind study of N-(4-Hydroxyphenyl) retinamide (4-HPR) versus placebo in patients with cervical intraepithelial neoplasia (CIN) grade 2-3

Trial Profile

A randomized double-blind study of N-(4-Hydroxyphenyl) retinamide (4-HPR) versus placebo in patients with cervical intraepithelial neoplasia (CIN) grade 2-3

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Aug 2010

At a glance

  • Drugs Fenretinide (Primary)
  • Indications Cervical cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top